VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer <i>in vivo</i>Guangbo Kang, He Huang, He Ren et al.|Cancer Biology and Medicine|2021Cited by 19
BFGF Mitigates CTX-Induced Ovarian Cytotoxicity via SERPINE1/HIF-1 and Nrf-2/HO-1 Signaling PathwaysYao Li, Min Hu|Research Square|2025Cited by 0